Instem Enters Early Phase Clinical Market; Acquires Logos Technologies and ALPHADAS

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that it has acquired Logos Technologies (“Logos”) representing its strategic move into the early phase clinical trials market.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC